Read Multiple Sclerosis News Today’s full, ongoing coverage of the Ocrevus approval:

News:

FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive Forms

Ocrevus’ Journey from Defiant Idea to Game-Changing Treatment

Ocrevus and the Hope of ‘Ending MS Forever’: Interview with MS Society’s Tim Coetzee

Social Media:

5 Things to Know About the New MS Drug Ocrevus

Stay tuned for additional follow-up coverage throughout the week on Multiple Sclerosis News Today, including:

• Reaction statements from Genentech, the National Multiple Sclerosis Society, and other major MS influencers on the approval.
• Exclusive interview with Dr. Peter Chin, Group Medical Director for Neuroscience, US Medical Affairs at Genentech.
• Exclusive interview with Tim Coetzee, Chief Advocacy, Services, and Research Officer (NMSS) on Ocrevus and issues of importance.
• Interviews with MS patients, as well as Multiple Sclerosis News Today columnists, on reaction of the Ocrevus approval.